Singapore, May 16 -- The Abu Dhabi Public Health Centre (ADPHC) has signed a two-year Memorandum of Understanding (MoU) with Gilead Sciences Ireland to enhance disease prevention, early detection, and public awareness in key health areas in Abu Dhabi Emirate.

The MoU establishes a framework for collaboration between ADPHC and Gilead Sciences across two core pillars: disease awareness and education campaigns and screening and early detection and diagnosis. The partnership will focus on blood-borne viruses, including hepatitis B (HBV), hepatitis C (HCV), and HIV.

Key activities under the MoU include co-developing public awareness campaigns across digital and traditional platforms, promoting proactive screening among high-risk populations,...